Patent · US Active

Treatment of gliomas using organonitro compound combination therapy

US10543208B2 · kind B2 · utility

11Cited by
34References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2018
Grant dateJan 28, 2020
Priority date—
Expiry dateMay 25, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N5/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides therapeutic methods and kits for treating a glioma using a particular dosing regimen of the organonitro compound ABDNAZ, radiation therapy, and one of temozolomide, irinotecan, or bevacizumab.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.